Next to the ICT sector, biotechnology is one of the most promising areas for the development of a knowledge-based and data-driven economy in Poland. In order for Polish biotechnology to become one of the leaders, it is necessary to create conditions that will stimulate development and innovation. For this reason, 11 biotechnology companies have joined together to form BioInMed - the Polish Association of Innovative Medical Biotechnology Companies.
Captor Therapeutics is one of the founding members of BioInMed, along with companies such as Ardigen, Celon Pharma, ExploRNA Therapeutics, OncoArendi Therapeutics, the Polish Stem Cell Bank, PolTREG, Pure Biologics, Ryvu Therapeutics, Selvita and WPD Pharmaceuticals.
The Polish Association of Innovative Medical Biotechnology Companies was established to work with all stakeholders and public administrations in order to build an ecosystem that will allow medical biotechnology to become a flagship sector of Polish innovation and a major driving force for the new economy.
More information about BioInMed is available on: www.bioinmed.pl
